Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Jefferam1on Mar 29, 2017 12:07am
155 Views
Post# 26044499

RE:My daughter the nerd asks real questions

RE:My daughter the nerd asks real questionsCorrect me if I'm wrong but much of the past test done with NicOx was using NO (Nitric Oxide) as the hybrid compound rather than H2S (Hydrogen Sulfide).
NO has a higher risk of toxicity where H2S has lower risk even at high dosage.
Feel free to read the article below for some details.
https://www.medscape.com/viewarticle/734878
I only started investigating more into NicOx and JL Wallace past.
To me it seems like he started down the NO path but discovered H2S to be safer and  have more favorable results.
In the end, it just sounds like ATB-346 is superior to alternatives.
Unfortunately a lot of the articles I was reading are very technical and a bit out of my comfort zone to have a full handle on it.
The one part that concerns me is the comment below:
"The same authors have also synthesized an ester (ATB-346) between naproxen and the 4-hydroxybenzothioamide (TBZ)"
Then later:
" Moreover, thiobenzamide and its para-substituted derivatives have been described as characterized by different degrees of hepato- and/or nephro-toxicity, both of which could worsen the known renal and hepatic adverse effects of NSAIDs"
One last quote
"The hydroxyl is a strong electron-donating group, whose inductive and resonance effects can be modulated by the ionization degree of 4-hydroxythiobenzamide at physiological pH. Thus the effective toxicological danger of this H2S-releasing moiety should be carefully assessed before using any of its derivatives as a drug. On the other hand, ADTOH, the metabolite of anethole dithiolethione (ADT) and of the described hybrid drugs, is endowed with hepatoprotective activity and ADT itself has been used for many years as a choleretic without adverse effects"
I think back at the failed clinical trial which was stopped because elevated liver enzymes.
Doesn't this imply that there may be some risk for potential hepatotoxicity? Can anyone care to translate this document to english.
All the same knowing that the dosage was too high could be the simple answer and so long as they are keeping dosing at right levels this might be a non issue. Too much of any drug can hurt you. Hopefully I just don't understand what it is they are talking about and this was just a wasted post.
From the what I've seen thus far, I'm still Long on Antibe. Lots of potential.
Bullboard Posts